Drug intelligence / Profile preview

Maxilene (lidocaine)

Development stage
Approved
Lead developer
RGR Pharma
Modality
Small Molecules
Administration
Topical
01

Overview

Maxilene is a topical anesthetic cream containing liposomal lidocaine, specifically formulated to provide localized pain relief. It is frequently utilized in clinical settings, such as those at The Hospital for Sick Children, to mitigate pain associated with needle-related procedures, including influenza vaccinations, venipuncture, and minor dermatological surgeries. The liposomal delivery system enhances the penetration of the active ingredient through the skin's stratum corneum, allowing for a faster onset of action compared to traditional lidocaine formulations. Lidocaine, the active component, functions by reversibly blocking voltage-gated sodium channels on the internal surface of neuronal membranes. This action prevents the influx of sodium ions, thereby inhibiting the depolarization and subsequent propagation of pain signals along nerve fibers. In clinical trials, Maxilene has been evaluated as a primary analgesic strategy to improve patient comfort during routine medical interventions.

Brand names
Maxilene
Other names
liposomal lidocaine
02

Targets

TLR4 (Toll-like receptor 4)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Maxilene (lidocaine).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maxilene (lidocaine).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call